|Articles|February 1, 2004
Dermal substitutes
Washington, D.C. - The competition among dermal substitute manufacturers to meet the needs of a burgeoning population of chronic wound sufferers has resulted in a growth market of continually improving products, said Eliot N. Mostow, M.D., dermatologist and wound care specialist in Akron, Ohio.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
Expert Panel Unanimously Backs DecisionDx-Melanoma for Guiding Personalized Cancer Care
4
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
5













